Acute myelogenous leukemia-derived SMAD4 mutations target the protein to ubiquitin-proteasome degradation

Lei Yang, Ning Wang, Yi Tang, Xu Cao, Mei Wan

Research output: Contribution to journalArticle

Abstract

Disruption of transforming growth factor-β (TGFB1/IGF-β) signaling contributes to the formation of human hematological malignancies. Smad4, a tumor suppressor, functions as an essential intracellular signal transducer of the TGF-β signaling pathway. Recent studies have demonstrated that some tumor-derived mutations of Smad4 are associated with protein instability; however, the precise mechanism by which mutated Smad4 proteins undergo rapid degradation remains to be elucidated. A missense mutation of the SMAD4 gene in the Mad homology 1 (MH1) domain (c.305C>T, Pro102Leu) and one frameshift mutation resulting in termination in the Mad homology 2 (MH2) domain (c.1447_1448insAATA, Δ483-552) have been identified in acute myelogenous leukemia. It is not known whether protein instability of these SMAD4 mutants is one of the contributors to TGF-β signaling disruption in acute myelogenous leukemia. Here we report that these two acute myelogenous leukemia-derived SMAD4 mutants are degraded rapidly when compared to their wild-type counterpart. We have demonstrated that both mutated proteins exhibit enhanced polyubiquitination (or polyubiquitylation) and proteasomal degradation. Importantly, we found that β-transducin-repeat-containing protein 1 (β-TrCP1), an F-box protein in the ubiquitin E3 ligase Skp1-Cullin-F-box protein (SCF) complex, directly interacts with and acts as a critical determinant for degradation of both mutated SMAD4 proteins. In addition, small interference RNA (siRNA)-triggered endogenous β-TrCP1 suppression increased the protein expression level of both overexpressed SMAD4 mutants and endogenous mutated SMAD4 protein in acute myelogenous leukemia cells. These data suggest that mutated SMAD4 proteins undergo rapid degradation in acute myelogenous leukemia cells via SCF β-TrCP1 E3 ligase-mediated protein ubiquitination (or ubiquitylation) and subsequent proteasomal degradation.

Original languageEnglish (US)
Pages (from-to)897-905
Number of pages9
JournalHuman Mutation
Volume27
Issue number9
DOIs
StatePublished - Sep 2006
Externally publishedYes

Fingerprint

Proteasome Endopeptidase Complex
Ubiquitin
Acute Myeloid Leukemia
Mutation
Proteins
SKP Cullin F-Box Protein Ligases
Ubiquitin-Protein Ligases
Ubiquitination
Smad4 Protein
F-Box Proteins
Transducin
Frameshift Mutation
Transforming Growth Factors
Hematologic Neoplasms
Missense Mutation
RNA Interference
Transducers
Neoplasms

Keywords

  • β-TrCP1
  • Acute myelogenous leukemia
  • Protein instability
  • SMAD4 gene mutation
  • TGF-β
  • TGFB1
  • Ubiquitin-proteasome pathway

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Acute myelogenous leukemia-derived SMAD4 mutations target the protein to ubiquitin-proteasome degradation. / Yang, Lei; Wang, Ning; Tang, Yi; Cao, Xu; Wan, Mei.

In: Human Mutation, Vol. 27, No. 9, 09.2006, p. 897-905.

Research output: Contribution to journalArticle

@article{d37f8d18af6240fda40b647a0f374b62,
title = "Acute myelogenous leukemia-derived SMAD4 mutations target the protein to ubiquitin-proteasome degradation",
abstract = "Disruption of transforming growth factor-β (TGFB1/IGF-β) signaling contributes to the formation of human hematological malignancies. Smad4, a tumor suppressor, functions as an essential intracellular signal transducer of the TGF-β signaling pathway. Recent studies have demonstrated that some tumor-derived mutations of Smad4 are associated with protein instability; however, the precise mechanism by which mutated Smad4 proteins undergo rapid degradation remains to be elucidated. A missense mutation of the SMAD4 gene in the Mad homology 1 (MH1) domain (c.305C>T, Pro102Leu) and one frameshift mutation resulting in termination in the Mad homology 2 (MH2) domain (c.1447_1448insAATA, Δ483-552) have been identified in acute myelogenous leukemia. It is not known whether protein instability of these SMAD4 mutants is one of the contributors to TGF-β signaling disruption in acute myelogenous leukemia. Here we report that these two acute myelogenous leukemia-derived SMAD4 mutants are degraded rapidly when compared to their wild-type counterpart. We have demonstrated that both mutated proteins exhibit enhanced polyubiquitination (or polyubiquitylation) and proteasomal degradation. Importantly, we found that β-transducin-repeat-containing protein 1 (β-TrCP1), an F-box protein in the ubiquitin E3 ligase Skp1-Cullin-F-box protein (SCF) complex, directly interacts with and acts as a critical determinant for degradation of both mutated SMAD4 proteins. In addition, small interference RNA (siRNA)-triggered endogenous β-TrCP1 suppression increased the protein expression level of both overexpressed SMAD4 mutants and endogenous mutated SMAD4 protein in acute myelogenous leukemia cells. These data suggest that mutated SMAD4 proteins undergo rapid degradation in acute myelogenous leukemia cells via SCF β-TrCP1 E3 ligase-mediated protein ubiquitination (or ubiquitylation) and subsequent proteasomal degradation.",
keywords = "β-TrCP1, Acute myelogenous leukemia, Protein instability, SMAD4 gene mutation, TGF-β, TGFB1, Ubiquitin-proteasome pathway",
author = "Lei Yang and Ning Wang and Yi Tang and Xu Cao and Mei Wan",
year = "2006",
month = "9",
doi = "10.1002/humu.20387",
language = "English (US)",
volume = "27",
pages = "897--905",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "Wiley-Liss Inc.",
number = "9",

}

TY - JOUR

T1 - Acute myelogenous leukemia-derived SMAD4 mutations target the protein to ubiquitin-proteasome degradation

AU - Yang, Lei

AU - Wang, Ning

AU - Tang, Yi

AU - Cao, Xu

AU - Wan, Mei

PY - 2006/9

Y1 - 2006/9

N2 - Disruption of transforming growth factor-β (TGFB1/IGF-β) signaling contributes to the formation of human hematological malignancies. Smad4, a tumor suppressor, functions as an essential intracellular signal transducer of the TGF-β signaling pathway. Recent studies have demonstrated that some tumor-derived mutations of Smad4 are associated with protein instability; however, the precise mechanism by which mutated Smad4 proteins undergo rapid degradation remains to be elucidated. A missense mutation of the SMAD4 gene in the Mad homology 1 (MH1) domain (c.305C>T, Pro102Leu) and one frameshift mutation resulting in termination in the Mad homology 2 (MH2) domain (c.1447_1448insAATA, Δ483-552) have been identified in acute myelogenous leukemia. It is not known whether protein instability of these SMAD4 mutants is one of the contributors to TGF-β signaling disruption in acute myelogenous leukemia. Here we report that these two acute myelogenous leukemia-derived SMAD4 mutants are degraded rapidly when compared to their wild-type counterpart. We have demonstrated that both mutated proteins exhibit enhanced polyubiquitination (or polyubiquitylation) and proteasomal degradation. Importantly, we found that β-transducin-repeat-containing protein 1 (β-TrCP1), an F-box protein in the ubiquitin E3 ligase Skp1-Cullin-F-box protein (SCF) complex, directly interacts with and acts as a critical determinant for degradation of both mutated SMAD4 proteins. In addition, small interference RNA (siRNA)-triggered endogenous β-TrCP1 suppression increased the protein expression level of both overexpressed SMAD4 mutants and endogenous mutated SMAD4 protein in acute myelogenous leukemia cells. These data suggest that mutated SMAD4 proteins undergo rapid degradation in acute myelogenous leukemia cells via SCF β-TrCP1 E3 ligase-mediated protein ubiquitination (or ubiquitylation) and subsequent proteasomal degradation.

AB - Disruption of transforming growth factor-β (TGFB1/IGF-β) signaling contributes to the formation of human hematological malignancies. Smad4, a tumor suppressor, functions as an essential intracellular signal transducer of the TGF-β signaling pathway. Recent studies have demonstrated that some tumor-derived mutations of Smad4 are associated with protein instability; however, the precise mechanism by which mutated Smad4 proteins undergo rapid degradation remains to be elucidated. A missense mutation of the SMAD4 gene in the Mad homology 1 (MH1) domain (c.305C>T, Pro102Leu) and one frameshift mutation resulting in termination in the Mad homology 2 (MH2) domain (c.1447_1448insAATA, Δ483-552) have been identified in acute myelogenous leukemia. It is not known whether protein instability of these SMAD4 mutants is one of the contributors to TGF-β signaling disruption in acute myelogenous leukemia. Here we report that these two acute myelogenous leukemia-derived SMAD4 mutants are degraded rapidly when compared to their wild-type counterpart. We have demonstrated that both mutated proteins exhibit enhanced polyubiquitination (or polyubiquitylation) and proteasomal degradation. Importantly, we found that β-transducin-repeat-containing protein 1 (β-TrCP1), an F-box protein in the ubiquitin E3 ligase Skp1-Cullin-F-box protein (SCF) complex, directly interacts with and acts as a critical determinant for degradation of both mutated SMAD4 proteins. In addition, small interference RNA (siRNA)-triggered endogenous β-TrCP1 suppression increased the protein expression level of both overexpressed SMAD4 mutants and endogenous mutated SMAD4 protein in acute myelogenous leukemia cells. These data suggest that mutated SMAD4 proteins undergo rapid degradation in acute myelogenous leukemia cells via SCF β-TrCP1 E3 ligase-mediated protein ubiquitination (or ubiquitylation) and subsequent proteasomal degradation.

KW - β-TrCP1

KW - Acute myelogenous leukemia

KW - Protein instability

KW - SMAD4 gene mutation

KW - TGF-β

KW - TGFB1

KW - Ubiquitin-proteasome pathway

UR - http://www.scopus.com/inward/record.url?scp=33748344500&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748344500&partnerID=8YFLogxK

U2 - 10.1002/humu.20387

DO - 10.1002/humu.20387

M3 - Article

VL - 27

SP - 897

EP - 905

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 9

ER -